dnatrix.comContact us
About company
DNAtrix is a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer. DNAtrix’s lead product, DNX-2401, is a modified common cold virus that targets and kills cancer cells selectively.
US 2450 holcombe boulevard
Unknown
Not verified company
